Ducord Market Report 2026

Ducord Market Overview

• The Ducord market growth in the historic period has been driven by need for alternative stem cell sources, growth of transplant medicine • Market expansion is supported by growth in stem cell research funding, rising transplant success rates • Growth Driver: Increasing Incidence Of Blood Disorders Fuels Growth Of Ducord Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Ducord Market?

Ducord is a stem cell therapy derived from umbilical cord blood, primarily used in hematopoietic stem cell transplants. It assists in regenerating the blood and immune systems in patients with hematopoietic disorders, including those undergoing myeloablative treatments. The therapy has demonstrated potential in treating both genetic and acquired conditions. The main indication for ducord are hematopoietic stem cell transplantation, regenerative medicine. Hematopoietic stem cell transplantation (HSCT) is a medical procedure that involves transplanting hematopoietic stem cells to restore the production of blood cells and immune function in patients with certain blood disorders. These are distributed through various distribution channels such as cord blood banks, hospitals and transplant centers, research institutions and are used in various applications such as diagnostics, biomanufacturing.

What Is The Ducord Market Growth Forecast?

The growth in the forecast period can be attributed to growth in stem cell research funding, rising transplant success rates, expansion of regenerative therapies, increased awareness of cord blood benefits, healthcare infrastructure development. Major trends in the forecast period include growing adoption of cord blood stem cell therapy, expansion of hematopoietic transplant procedures, rising use in regenerative medicine, strengthening of cord blood banking, advancements in cell processing technologies.

Global Ducord Market Segmentation

1) By Indication: Hematopoietic Stem Cell Transplantation, Regenerative Medicine 2) By Distribution Channel: Cord Blood Banks, Hospitals and Transplant Centers, Research Institutions 3) By Application: Diagnostics, Biomanufacturing

What Are The Drivers Of The Ducord Market?

The growing incidence of blood disorders is expected to propel the growth of ducord market going forward. Blood disorders refer to conditions that affect the production, function, or structure of blood cells, leading to issues such as anemia, hemophilia, sickle cell disease, and clotting disorders. The increasing prevalence of blood disorders is due to factors such as genetic predispositions, an aging population, environmental influences, and lifestyle changes. Ducord, a pioneering stem cell-based therapy, helps patients suffering from blood disorders by harnessing the regenerative potential of cord blood stem cells to treat conditions such as leukemia, anemia, and immune deficiencies, offering patients a promising alternative to traditional treatments and the possibility of long-term remission. For instance, in April 2024, according to a report published by the Centers for Disease Control and Prevention, a US-based national public health agency, there were 2.8 million visits to physician offices for anemia as the primary diagnosis, with 6,021 deaths, resulting in a mortality rate of 1.8 deaths per 100,000 population. Therefore, the growing incidence of blood disorders drives the ducord industry. The rising healthcare spending is expected to propel the growth of the ducord market going forward. Healthcare spending refers to the funds allocated for medical services, treatments, and other healthcare-related expenses. The rising healthcare spending is driven by factors such as an aging population, increasing prevalence of chronic diseases, and advancements in medical technology. Healthcare expenditure supports Ducord by providing the necessary funding for research, development, and clinical trials, enabling the advancement and accessibility of innovative stem cell therapies that can revolutionize the treatment of blood disorders and other medical conditions. For instance, in May 2024, according to the Office for National Statistics, a UK-based government department, between 2022 and 2023, healthcare spending in the UK increased by 5.6% compared with the growth of 0.9% in 2022. The UK healthcare expenditure in UK healthcare expenditure was around $317.63 billion (£292 billion) in 2023. Therefore, rising healthcare spending is driving the growth of the ducord industry. The growing demand for minimally invasive treatments is expected to propel the growth of the ducord market going forward. Minimally invasive treatments refer to medical procedures that involve small or no incisions, offering reduced recovery time and lower risks compared to traditional surgeries. The growing demand for minimally invasive treatments is driven by factors such as faster recovery times, shorter hospital stays, and rising health awareness. Ducord focuses on creating innovative devices, such as catheters, endoscopes, and other diagnostic tools, that support minimally invasive procedures, enabling physicians to perform surgeries with smaller incisions, thereby reducing recovery times and complications for patients. For instance, in April 2025, according to the British Association of Aesthetic Plastic Surgeons, a UK-based surgical organization, between 2023 and 2024, cosmetic surgical procedures increased by 5%, reaching a total of 27,462 procedures performed in 2024. Therefore, growing demand for minimally invasive treatments is driving the growth of the ducord industry.

Key Players In The Global Ducord Market

Major companies operating in the ducord market are Duke University School Of Medicine

Regional Insights

North America was the largest region in the ducord market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Ducord Market?

The ducord market consists of sales of cord blood, cord blood-derived progenitor cells, and cryopreserved cord blood. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Ducord Market Report 2026?

The ducord market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the ducord industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.